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SUMMARY Calciphylaxis is a rare, but potentially life-threatening con-
dition usually observed in patients with end-stage chronic renal disease 
and characterized by small- and medium-sized blood vessel calcification 
leading to tissue ischemia. The clinical features are primarily cutaneous, 
consisting of skin necrosis and ulceration, mostly located in the lower ex-
tremities. We report a case of a 56-year-old woman with a previous his-
tory of renal disease and atypical lobular hyperplasia of the right breast, 
who developed painful skin necrosis on both breasts. Differential diagnosis 
comprises acute bacterial infection with ulceration, cutaneous vasculitis, 
cancer and calciphylaxis.
KeY woRdS: calciphylaxis, calcific uremic arteriolopathy, chronic renal 
failure, breast cancer, breast necrosis
Abbreviations: DDx:  Differential diagnosis; CUA: calcific uremic arterio-
lopathy; PTH: parathyroid hormone.
IntRodUCtIon
Calciphylaxis, recently renamed as “calcific 
uremic arteriolopathy” (CUA) (1), is a rare, but 
potentially life-threatening complication typically 
developing in patients with end-stage renal dis-
ease (2). Histologic examination shows involve-
ment of small- and medium-sized blood vessels in 
the dermis and subcutaneous tissue with medial 
calcification and intimal hypertrophy. Microthrom-
bosis with complete occlusion of vascular lumen 
and subcutaneous tissue calcification can also be 
observed (3).
The exact etiology of CUA still remains uncer-
tain. High serum levels of the calcium-phosphate 
product and/or parathyroid hormone (PTH) have 
been implicated in the pathogenesis and possi-
bly represent predisposing factors in patients with 
chronic renal failure; other factors might be the 
triggers of ischemic changes in CUA (4-7).
The main clinical involvement is cutaneous and 
consists of painful violaceous plaque and subcuta-
neous nodules which progress to tissue necrosis, 
sometimes associated with livedo reticularis. Gen-
erally, the lesions are symmetrical and affect distal 
limbs, buttocks or abdomen (4,8).
CUA of the breast has rarely been reported 
in the literature so far. Since most patients with 
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chronic renal failure present an altered immune 
function with chronic hypertension, chronic ane-
mia and impaired coagulation, several differential 
diagnoses should be taken into account (9-12).
CASe RepoRt
A 56-year-old Caucasian woman was admit-
ted to our department for painful and necrotizing 
lesions on both breasts without history of local 
trauma. She was affected by chronic renal failure 
secondary to membranoproliferative glomerulo-
nephritis treated with chronic hemodialysis. Her 
medical history included atypical lobular hyperpla-
sia of the right breast, hypertensive cardiomyopa-
thy, hypothyroidism, obesity and nicotine abuse.
Physical examination revealed ulcerated, vio-
laceous, subcutaneous plaques located symmetri-
cally on both breasts close to the areola mammae 
(Fig. 1); axillary lymph nodes were bilaterally en-
larged.
On admission, laboratory investigations 
showed microcytic anemia, high serum values 
of creatinine (6.70 mg/dL; range: 0.7-1.4 mg/dL), 
blood urea nitrogen (173 mg/dL; range: 17-50 
mg/dL), PTH (1800 pg/mL; range: 11-64 pg/mL), 
phosphate (6.65 mg/dL; range: 2.50-4.50 mg/dL), 
and hypoalbuminemia. All other laboratory tests 
including autoantibodies were within the normal 
range.
Sonography of the breast showed acute in-
flammation around the areola mammae. The pa-
tient refused to give her consent for mammogra-
phy because of the severe local pain. Firstly she 
was treated with cefodizime and ciprofloxacin. 
Biopsy of the lesion revealed mural calcification 
and intimal hypertrophy of the small arterioles of 
the dermis (Fig. 2) of adipose tissue, and calci-
fications in the subcutaneous tissue. These find-
ings were confirmed by von Kossa’s silver staining 
(Fig. 3), suggesting the diagnosis of CUA. During 
hospitalization the patient developed symmetric 
necrotic lesions on the upper abdomen with livedo 
reticularis, again confirmed as CUA on histologic 
examination.
Due to the enlargement of tissue damage, right 
mastectomy had to be performed. Postopera-
tive histologic analysis showed severe ischemic 
necrosis caused by complete vascular occlusion 
together with extensive calcification of subcutane-
ous adipose tissue.
Partial parathyroidectomy was also performed 
for secondary hyperparathyroidism; after the sur-
gery serum PTH levels decreased and serum 
phosphate values returned to normal.
The patient’s condition further improved and 
she could be dismissed. The 4-month follow up 
period was unnoticeable, but subsequently an 
Figure 1. Calciphylaxis of the breast: violaceous 
and necrotizing skin lesions. Note involvement of 
areola mammae. Figure 2.  Arterioles of the dermis show medial 
calcification and intimal hypertrophy (hematoxylin-
eosin stain).
Figure 3. Subcutaneous adipose tissue: calcium 
deposits in the vessel wall (von Kossa’s stain).
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abrupt increase in PTH (up to 1600 pg/mL) was 
observed. Treatment with cinacalcet was started 
(30 mg/day/os). This dose was increased to 60 
mg/day/per 2 weeks later; cinacalcet was always 
well tolerated. The patient was followed-up for an-
other 6 months; her skin as well as serum calcium 
and phosphate levels were within the normal val-
ues.
dISCUSSIon And ConClUSIonS
In this report we describe a case of CUA pre-
sented with painful necrotizing lesions of the 
breast, surrounding inflammation and palpable 
lymph nodes in both axillae. CUA of the breast 
has rarely been described in literature so far. The 
disease can clinically mimic several disorders, 
among them acute bacterial infection, cutaneous 
vasculitis or breast cancer. CUA is in most cases 
associated with chronic renal failure, but has also 
been described in patients with normal renal func-
tion (9-12). 
Our patient was affected by chronic renal fail-
ure with secondary hyperparathyroidism. No labo-
ratory signs of autoimmunity were detected. She 
also had a history of atypical lobular hyperplasia of 
the right mammary gland. Atypical lobular hyper-
plasia is a benign condition, but is associated with 
an increased risk of developing invasive cancer 
in both breasts, often located close to the areola 
mammae; it was the case in this patient (13). His-
tological examination of breast tissue was crucial 
to exclude a breast neoplasm and to achieve the 
final diagnosis of CUA.
CUA is a rare condition. It is associated with 
a high mortality, often due to secondary sepsis of 
cutaneous gangrenous ulcers (7).
Therapeutic options for CUA are aimed at pre-
venting infections and including modifications of 
factors such as elevated calcium-phosphate prod-
uct and/or PTH level, which can affect disease pro-
gression. Medical interventions include cinacalcet, 
a calcimimetic recently approved for the treatment 
of patients with secondary hyperparathyroidism 
and chronic kidney disease (7,15-17). Surgical 
treatment of CUA consists in parathyroidectomy, 
with better wound healing and longer-term surviv-
al according to several reports (18). Conventional 
ulcer therapies are usually ineffective for cutane-
ous lesions in calciphylaxis (7).
The patient was firstly treated with systemic 
antibiotics, and secondly with mastectomy of the 
right breast. Partial parathyroidectomy was also 
performed to correct hyperparathyroidism. After 
that, impressive improvement of cutaneous le-
sions and pain relief were observed. Partial para-
thyroidectomy was preferred to total parathyroid-
ectomy because of the risk of permanent hypo-
parathyroidism (18). Nevertheless, 4-6 months 
after surgery, a significant increase of PTH levels 
was observed again. Recurrent hyperparathyroid-
ism has been described as a possible complica-
tion of partial parathyroidectomy treatable by new 
gland resection (19). The use of cinacalcet as a 
second line therapy reduced hyperparathyroid-
ism within a few days. During the next 6 months 
cinacalcet was continued, achieving good control 
of the calcium-phosphate product and PTH serum 
levels as well as of the skin condition.
CUA of the breast is a rare disease which can 
present with cutaneous necrosis and reactive 
lymphadenopathy, thus mimicking breast cancer. 
CUA of the breast should be considered as a dif-
ferential diagnosis in all cases of breast necrosis, 
particularly when associated with chronic renal 
failure.
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